ScienceLatest
FDA's View on Peptide Compounding and Trial Recruitment Issues
The FDA's perspective on peptide compounding is under scrutiny as it impacts the pharmaceutical landscape. Additionally, the ongoing conflict in Iran is affecting recruitment for clinical trials, raising concerns in the industry.
0 upvotes
What happened
The FDA's perspective on peptide compounding is under scrutiny as it impacts the pharmaceutical landscape.
Why it matters
Additionally, the ongoing conflict in Iran is affecting recruitment for clinical trials, raising concerns in the industry.